Promotion of inflammatory arthritis by interferon regulatory factor 5 in a mouse model

Arthritis and Rheumatology

Volumn 67, Issue 12, 2015, Pages 3146-3157

  Duffau, Pierre ^a,b   Menn Josephy, Hanni ^b   Cuda, Carla M ^c   Dominguez, Salina ^c   Aprahamian, Tamar R ^b   Watkins, Amanda A ^b   Yasuda, Kei ^b   Monach, Paul ^b   Lafyatis, Robert ^b   Rice, Lisa M ^b   Kenneth Haines, G ^d   Gravallese, Ellen M ^e   Baum, Rebecca ^e   Richez, Christophe ^f   Perlman, Harris ^c   Bonegio, Ramon G ^b   Rifkin, Ian R ^b  

^a HÔPITAL SAINT ANDRÉ   (France)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f HÔPITAL PELLEGRIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN G; COLONY STIMULATING FACTOR 1; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; NITRIC OXIDE; PATTERN RECOGNITION RECEPTOR; PROTEINASE; RNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; IL1B PROTEIN, MOUSE; INTERFERON REGULATORY FACTOR; IRF5 PROTEIN, MOUSE; MEMBRANE PROTEIN; TICAM-1 PROTEIN, MOUSE; TLR2 PROTEIN, MOUSE; TLR3 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE; TLR7 PROTEIN, MOUSE; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ADHERENT CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MARROW DERIVED MACROPHAGE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; EMBRYO; GENE EXPRESSION; IN VITRO STUDY; KERATINOCYTE; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; DISEASE MODEL; EXPERIMENTAL ARTHRITIS; GENE SILENCING; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; SEVERITY OF ILLNESS INDEX; SYNOVIAL FLUID;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; DISEASE MODELS, ANIMAL; GENE KNOCKDOWN TECHNIQUES; IN VITRO TECHNIQUES; INTERFERON REGULATORY FACTORS; INTERLEUKIN-1BETA; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID CELLS; RECEPTORS, INTERLEUKIN-1; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; SYNOVIAL FLUID; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 7;

EID: 84948437452     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39321     Document Type: Article

References (50)

1. McInnes IB, O'Dell JR., State-of-the-art: rheumatoid arthritis. Ann Rheum Dis 2010; 69: 1898-906.
2. Dieguez-Gonzalez R, Calaza M, Perez-Pampin E, de la Serna AR, Fernandez-Gutierrez B, Castaneda S, et al., Association of interferon regulatory factor 5 haplotypes, similar to that found in systemic lupus erythematosus, in a large subgroup of patients with rheumatoid arthritis. Arthritis Rheum 2008; 58: 1264-74.
3. Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP, et al., Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 2010; 42: 508-14.
4. Cham CM, Ko K, Niewold TB., Interferon regulatory factor 5 in the pathogenesis of systemic lupus erythematosus. Clin Dev Immunol 2012; 2012: 780436.
5. Monach P, Hattori K, Huang H, Hyatt E, Morse J, Nguyen L, et al., The K/BxN mouse model of inflammatory arthritis: theory and practice. Methods Mol Med 2007; 136: 269-82.
6. Ditzel HJ., The K/BxN mouse: a model of human inflammatory arthritis. Trends Mol Med 2004; 10: 40-5.
7. Wu X, Shih F, Atkinson JP., Systemic humoral autoimmunity but joint-specific inflammation: the syndrome of rheumatoid arthritis [editorial]. Arthritis Rheum 2007; 56: 2823-8.
8. Purtha WE, Swiecki M, Colonna M, Diamond MS, Bhattacharya D., Spontaneous mutation of the Dock2 gene in Irf5-/- mice complicates interpretation of type I interferon production and antibody responses. Proc Natl Acad Sci U S A 2012; 109: E898-904.
9. Yasuda K, Nundel K, Watkins AA, Dhawan T, Bonegio RG, Ubellacker JM, et al., Phenotype and function of B cells and dendritic cells from interferon regulatory factor 5-deficient mice with and without a mutation in DOCK2. Int Immunol 2013; 25: 295-306.
10. - monocytes drive the development of inflammatory arthritis in mice. Cell Rep 2014; 9: 591-604.
11. Scatizzi JC, Bickel E, Hutcheson J, Haines GK III, Perlman H., Bim deficiency leads to exacerbation and prolongation of joint inflammation in experimental arthritis. Arthritis Rheum 2006; 54: 3182-93.
12. Watkins AA, Yasuda K, Wilson GE, Aprahamian T, Xie Y, Maganto-Garcia E, et al., IRF5 deficiency ameliorates lupus but promotes atherosclerosis and metabolic dysfunction in a mouse model of lupus-associated atherosclerosis. J Immunol 2015; 194: 1467-79.
13. Case JP, Sano H, Lafyatis R, Remmers EF, Kumkumian GK, Wilder RL., Transin/stromelysin expression in the synovium of rats with experimental erosive arthritis: in situ localization and kinetics of expression of the transformation-associated metalloproteinase in euthymic and athymic Lewis rats. J Clin Invest 1989; 84: 1731-40.
14. Yasuda K, Richez C, Maciaszek JW, Agrawal N, Akira S, Marshak-Rothstein A, et al., Murine dendritic cell type I IFN production induced by human IgG-RNA immune complexes is IFN regulatory factor (IRF)5 and IRF7 dependent and is required for IL-6 production. J Immunol 2007; 178: 6876-85.
15. Ji H, Pettit A, Ohmura K, Ortiz-Lopez A, Duchatelle V, Degott C, et al., Critical roles for interleukin 1 and tumor necrosis factor α in antibody-induced arthritis. J Exp Med 2002; 196: 77-85.
16. Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, Sakagami M, et al., Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 1998; 9: 143-50.
17. Takaoka A, Yanai H, Kondo S, Duncan G, Negishi H, Mizutani T, et al., Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 2005; 434: 243-9.
18. Schoenemeyer A, Barnes BJ, Mancl ME, Latz E, Goutagny N, Pitha PM, et al., The interferon regulatory factor, IRF5, is a central mediator of Toll-like receptor 7 signaling. J Biol Chem 2005; 280: 17005-12.
19. Jacobs JP, Ortiz-Lopez A, Campbell JJ, Gerard CJ, Mathis D, Benoist C., Deficiency of CXCR2, but not other chemokine receptors, attenuates autoantibody-mediated arthritis in a murine model. Arthritis Rheum 2010; 62: 1921-32.
20. Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, et al., Functional role of type I and type II interferons in antiviral defense. Science 1994; 264: 1918-21.
21. Kawai T, Akira S., The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010; 11: 373-84.
22. Marshak-Rothstein A, Rifkin IR., Immunologically active autoantigens: the role of Toll-like receptors in the development of chronic inflammatory disease. Annu Rev Immunol 2007; 25: 419-41.
23. Choe JY, Crain B, Wu SR, Corr M., Interleukin 1 receptor dependence of serum transferred arthritis can be circumvented by Toll-like receptor 4 signaling. J Exp Med 2003; 197: 537-42.
24. Wu HJ, Sawaya H, Binstadt B, Brickelmaier M, Blasius A, Gorelik L, et al., Inflammatory arthritis can be reined in by CpG-induced DC-NK cell cross talk. J Exp Med 2007; 204: 1911-22.
25. Goh FG, Midwood KS., Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis. Rheumatology (Oxford) 2012; 51: 7-23.
26. Bartok B, Firestein GS., Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev 2010; 233: 233-55.
27. Huang Q, Pope RM., Toll-like receptor signaling: a potential link among rheumatoid arthritis, systemic lupus, and atherosclerosis. J Leukoc Biol 2010; 88: 253-62.
28. Solomon S, Rajasekaran N, Jeisy-Walder E, Snapper SB, Illges H., A crucial role for macrophages in the pathology of K/B × N serum-induced arthritis. Eur J Immunol 2005; 35: 3064-73.
29. Bruhns P, Samuelsson A, Pollard JW, Ravetch JV., Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease. Immunity 2003; 18: 573-81.
30. Hamilton JA., Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol 2008; 8: 533-44.
31. Joosten LA, Netea MG, Fantuzzi G, Koenders MI, Helsen MM, Sparrer H, et al., Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1β. Arthritis Rheum 2009; 60: 3651-62.
32. Meyer-Hoffert U, Wiedow O., Neutrophil serine proteases: mediators of innate immune responses. Curr Opin Hematol 2011; 18: 19-24.
33. Ghasemzadeh M, Kaplan ZS, Alwis I, Schoenwaelder SM, Ashworth KJ, Westein E, et al., The CXCR1/2 ligand NAP-2 promotes directed intravascular leukocyte migration through platelet thrombi. Blood 2013; 121: 4555-66.
34. Kahlenberg JM, Kaplan MJ., Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease. J Immunol 2013; 191: 4895-901.
35. Markowitz J, Carson WE III,. Review of S100A9 biology and its role in cancer. Biochim Biophys Acta 2013; 1835: 100-9.
36. Ryckman C, Vandal K, Rouleau P, Talbot M, Tessier PA., Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J Immunol 2003; 170: 3233-42.
37. Wong SH, Francis N, Chahal H, Raza K, Salmon M, Scheel-Toellner D, et al., Lactoferrin is a survival factor for neutrophils in rheumatoid synovial fluid. Rheumatology (Oxford) 2009; 48: 39-44.
38. Wipke BT, Allen PM., Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J Immunol 2001; 167: 1601-8.
39. Alzabin S, Kong P, Medghalchi M, Palfreeman A, Williams R, Sacre S., Investigation of the role of endosomal Toll-like receptors in murine collagen-induced arthritis reveals a potential role for TLR7 in disease maintenance. Arthritis Res Ther 2012; 14: R142.
40. Chen SY, Shiau AL, Li YT, Lin YS, Lee CH, Wu CL, et al., Suppression of collagen-induced arthritis by intra-articular lentiviral vector-mediated delivery of Toll-like receptor 7 short hairpin RNA gene. Gene Ther 2012; 19: 752-60.
41. Huang QQ, Pope RM., The role of Toll-like receptors in rheumatoid arthritis. Curr Rheumatol Rep 2009; 11: 357-64.
42. Brentano F, Schorr O, Gay RE, Gay S, Kyburz D., RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3. Arthritis Rheum 2005; 52: 2656-65.
43. Monach PA, Hueber W, Kessler B, Tomooka BH, BenBarak M, Simmons BP, et al., A broad screen for targets of immune complexes decorating arthritic joints highlights deposition of nucleosomes in rheumatoid arthritis. Proc Natl Acad Sci U S A 2009; 106: 15867-72.
44. Bokarewa M, Tarkowski A, Lind M, Dahlberg L, Magnusson M., Arthritogenic dsRNA is present in synovial fluid from rheumatoid arthritis patients with an erosive disease course. Eur J Immunol 2008; 38: 3237-44.
45. Chamberlain ND, Kim SJ, Vila OM, Volin MV, Volkov S, Pope RM, et al., Ligation of TLR7 by rheumatoid arthritis synovial fluid single strand RNA induces transcription of TNFα in monocytes. Ann Rheum Dis 2013; 72: 418-26.
46. Cavassani KA, Ishii M, Wen H, Schaller MA, Lincoln PM, Lukacs NW, et al., TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J Exp Med 2008; 205: 2609-21.
47. Ganguly D, Chamilos G, Lande R, Gregorio J, Meller S, Facchinetti V, et al., Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J Exp Med 2009; 206: 1983-94.
48. Ouyang X, Negishi H, Takeda R, Fujita Y, Taniguchi T, Honda K., Cooperation between MyD88 and TRIF pathways in TLR synergy via IRF5 activation. Biochem Biophys Res Commun 2007; 354: 1045-51.
49. Ji H, Ohmura K, Mahmood U, Lee DM, Hofhuis FM, Boackle SA, et al., Arthritis critically dependent on innate immune system players. Immunity 2002; 16: 157-68.
50. H17 responses. Nat Immunol 2011; 12: 231-8.